Companies/EU/EXENS

EXOSENS

Last · Paris€56.85-1.05 (-1.81%)stale · yahoo · 43h ago
Vol 14.0K ≈ 810.2K
Market cap€2.9B50.7M sh
P/E · TTM132fwd 23.4 · eps 0.43
Beta0.81vs S&P 500
Div yield0.52%annual · TTM
52w range
€40.00€74.00
Volume15.1Ksession

Issuer

Legal nameEXOSENS
HQEurope (EU)
ListingEU EXENS
ISINFR001400Q9V2
LEI969500R3AKTPEDO9EG76
SectorIndustrials
IndustryAerospace & Defense
CurrencyEUR
Entity registrylei:969500R3AKTPEDO9EG76
Websitewww.exosens.com
Employees1,499
AddressMimbeau Holding SAS 18 avenue de Pythagore 33700, Mérignac
Headline financial metrics
Revenue€468.2M
Operating income€102.0M
Net income€42.7M
Free cash flow€-13.8M
Operating margin21.8%
Net margin9.1%
Return on equity9.6%
Period2025
Loading chart…

Upcoming earnings

1 event
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
136.7M
View upcoming earnings →

Earnings transcripts

2 recent

Press & signals

3 of 10 recent
  • GlobeNewswire

    Exosens supports the accelerating deployment of next-generation nuclear technologies in the U.S.

  • GlobeNewswire

    Monthly information on the total number of shares and voting rights in the share capital

  • GlobeNewswire

    Exosens raises full-year 2026 guidance, driven by faster-than-expected capacity ramp-up and strong commercial momentum

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
8-KExosens supports the accelerating deployment of next-generation nuclear technologies in the U.S.
2026-10-082026-10-080
DISCLOSUREMonthly information on the total number of shares and voting rights in the share capital
2026-10-012026-10-010
8-KExosens relève ses objectifs pour l’exercice 2026, grâce à une montée en cadence plus rapide que prévu des capacités de production et à une forte dynamique commerciale
2026-09-172026-09-170
Showing 5 of 134 filings